Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
13.70
0.22 (1.63%)
At close: Aug 19, 2025, 3:59 PM
13.71
0.07%
After-hours: Aug 19, 2025, 05:01 PM EDT
Avadel Pharmaceuticals Revenue
Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending March 31, 2025, Avadel Pharmaceuticals generated $52.51M in revenue.
Revenue (ttm)
169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
899.56K
Employees
188
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 169.12M | +504.79% |
| Dec 31, 2023 | 27.96M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | -100.00% |
| Dec 31, 2020 | 22.33M | -62.28% |
| Dec 31, 2019 | 59.22M | -42.66% |
| Dec 31, 2018 | 103.27M | -40.22% |
| Dec 31, 2017 | 172.74M | +14.97% |
| Dec 31, 2016 | 150.25M | -13.26% |
| Dec 31, 2015 | 173.21M | +1072.31% |
| Dec 31, 2014 | 14.78M | -34.17% |
| Dec 31, 2013 | 22.44M | -14.01% |
| Dec 31, 2012 | 26.1M | -19.94% |
| Dec 31, 2011 | 32.6M | -12.12% |
| Dec 31, 2010 | 37.09M | -11.93% |
| Dec 31, 2009 | 42.12M | +9.06% |
| Dec 31, 2008 | 38.62M | +5.36% |
| Dec 31, 2007 | 36.65M | +59.23% |
| Dec 31, 2006 | 23.02M | -2.45% |
| Dec 31, 2005 | 23.6M | -57.41% |
| Dec 31, 2004 | 55.41M | +120.17% |
| Dec 31, 2003 | 25.17M | +36.73% |
| Dec 31, 2002 | 18.41M | +40.64% |
| Dec 31, 2001 | 13.09M | +20.04% |
| Dec 31, 2000 | 10.9M | -1.25% |
| Dec 31, 1999 | 11.04M | +15.94% |
| Dec 31, 1998 | 9.52M | +17.56% |
| Dec 31, 1997 | 8.1M | +65.31% |
| Dec 31, 1996 | 4.9M | n/a |